Middle East Point of Care Glucose Testing Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Middle East Point of Care Glucose Testing Market Overview

• The Middle East Point of Care Glucose Testing Market is valued at USD 130 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of diabetes, rising awareness about diabetes management, and advancements in technology that enhance the accuracy, connectivity, and convenience of glucose testing devices, particularly for home and near-patient settings.
• Countries such as Saudi Arabia, the United Arab Emirates, and Egypt dominate the market due to their high rates of diabetes prevalence, expanding screening programs, and significant investments in healthcare infrastructure and digital health. These nations have implemented national noncommunicable disease and diabetes control policies that encourage early detection, regular monitoring, and wider use of point-of-care testing in primary care, hospitals, and community settings, making them key demand centers for glucose POCT devices.
• In 2023, the Saudi Arabian government further advanced its national diabetes and noncommunicable disease agenda through implementation of the National Strategy for Diabetes Prevention and Control under the Ministry of Health’s NCD programs, aligning with the Saudi Health Sector Transformation Program. This initiative includes strengthening primary care pathways, expanding access to glucose monitoring (including point-of-care glucose testing) across urban and rural regions, and integrating screening and follow-up into public health and digital platforms to improve early diagnosis and ongoing management for diabetes patients.

Middle East Point of Care Glucose Testing Market Segmentation

By Product Type:

The product type segmentation includes Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets and Lancing Devices, Continuous Glucose Monitoring (CGM) Systems and Sensors, Connectivity-Enabled / Networked Glucometers, and Others. SMBG Meters and associated consumables remain widely used; however, in value terms the market is increasingly supported by Test Strips and CGM Systems, which together account for a substantial share of regional point-of-care glucose revenues due to their recurrent use and higher per-patient spend. The convenience and ease of use of SMBG meters, combined with growing adoption of CGM and connectivity-enabled devices for real-time monitoring and integration with telehealth platforms, continue to support overall market growth in both clinical and home-care settings.

By End-User / Setting:

This segmentation includes Hospitals, Clinics and Physician Offices, Home Care & Self-Monitoring, Diagnostic Laboratories & Emergency Departments, and Others. Consistent with global trends, the Home Care & Self-Monitoring segment is a leading and fastest-growing user group, as more patients prefer to manage their diabetes at home with portable SMBG and CGM devices, supported by mobile applications and telehealth follow-up. Hospitals, clinics, and emergency departments also represent significant demand centers, using point-of-care glucose testing for rapid decision-making in acute and perioperative care, but the shift towards decentralized and patient-centric testing is increasingly influencing overall market dynamics in the Middle East.

Middle East Point of Care Glucose Testing Market Competitive Landscape

The Middle East Point of Care Glucose Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Roche Diabetes Care (F. Hoffmann-La Roche Ltd.), Abbott Diabetes Care (Abbott Laboratories), Ascensia Diabetes Care Holdings AG, LifeScan, Inc., Dexcom, Inc., Medtronic plc, Nova Biomedical Corporation, ARKRAY, Inc., ACON Laboratories, Inc., Ypsomed AG, Omron Healthcare Co., Ltd., Sanofi, Bionime Corporation, Trividia Health, Inc., and regional and local players contribute to innovation, geographic expansion, and service delivery in this space.

Middle East Point of Care Glucose Testing Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Diabetes:The Middle East faces a significant diabetes challenge, with approximately 75 million adults affected in the broader Middle East and North Africa region, according to the International Diabetes Federation. This alarming trend is driven by urbanization, sedentary lifestyles, and dietary changes. The growing diabetic population necessitates effective glucose monitoring solutions, propelling the demand for point of care testing devices that facilitate timely and accurate management of blood glucose levels.
• Rising Demand for Home Healthcare Solutions:The home healthcare market in the Middle East is expected to reach USD 12 billion in future, driven by an increasing preference for at-home medical care. Patients are seeking convenient and efficient ways to manage their health, particularly for chronic conditions like diabetes. Point of care glucose testing devices enable individuals to monitor their glucose levels from home, reducing the need for frequent hospital visits and enhancing patient autonomy in managing their health.
• Technological Advancements in Glucose Testing Devices:The Middle East is witnessing rapid advancements in glucose testing technology, with innovations such as continuous glucose monitoring (CGM) systems and smartphone-integrated devices. In future, the market for advanced glucose monitoring devices is valued at USD 1.5 billion, with expectations for significant growth as technology becomes more accessible. These advancements improve accuracy, ease of use, and patient engagement, driving adoption rates among both healthcare providers and patients.

Market Challenges

• High Cost of Advanced Testing Devices:The high price of advanced glucose testing devices remains a significant barrier to widespread adoption in the Middle East. For instance, CGM systems can cost upwards of USD 1,000, making them unaffordable for many patients. This financial constraint limits access to essential monitoring tools, particularly in lower-income populations, thereby hindering effective diabetes management and increasing the risk of complications associated with uncontrolled diabetes.
• Lack of Awareness Among Patients:Despite the rising prevalence of diabetes, there is a notable lack of awareness regarding the importance of regular glucose monitoring among patients in the Middle East. A survey indicated that only 40% of diabetic patients understood the significance of self-monitoring. This knowledge gap can lead to poor disease management and increased healthcare costs, as patients may not recognize the need for timely interventions or lifestyle changes to control their condition effectively.

Middle East Point of Care Glucose Testing Market Future Outlook

The future of the Middle East point of care glucose testing market appears promising, driven by increasing healthcare investments and a growing emphasis on chronic disease management. As telehealth services expand, patients will have greater access to remote monitoring solutions, enhancing their ability to manage diabetes effectively. Additionally, the integration of mobile health applications will facilitate real-time data sharing between patients and healthcare providers, fostering a more proactive approach to diabetes care and improving patient outcomes.

Market Opportunities

• Expansion of Telehealth Services:The telehealth market in the Middle East is projected to grow to USD 5 billion in future, creating opportunities for point of care glucose testing solutions. This growth will enable remote patient monitoring, allowing healthcare providers to offer personalized care and timely interventions, ultimately improving diabetes management and patient satisfaction.
• Development of User-Friendly Testing Devices:There is a significant opportunity for manufacturers to create user-friendly glucose testing devices tailored for diverse populations. By focusing on ease of use and accessibility, companies can tap into the growing demand for home healthcare solutions, thereby enhancing patient engagement and adherence to monitoring regimens.